Involvement of both IMN and SCN was associated worse outcomes in cN3 breast cancer.
The majority of disease recurrence events were distant metastases.
HER2-overexpressing phenotype demonstrated favourable outcomes.
Individualised treatment strategies considering these finding should be provided.